Clinical Trials Browser

Phase 3 × aflibercept × 1 year × Clear all

NCT00532155 2025-09-10

VITAL

Phase 3 Completed

913 enrolled 16 charts

Carcinoma, Lung Neoplasms

NCT03172299 2025-03-24

PROTECT

Phase 3 Completed

Uveal Melanoma